Ghrelin Treatment of Chronic Kidney Disease: Improvements in Lean Body Mass and Cytokine Profile
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Chronic kidney disease (CKD) is associated with an increase in inflammatory cytokines and can result in cachexia with loss of muscle and fat stores. We previously demonstrated the efficacy of treating a model of cancer cachexia with ghrelin and a ghrelin receptor agonist. Currently, we examine a surgical model of CKD in rats, resulting in uremia and decreased accrual of lean body mass. Treatment with ghrelin and two ghrelin receptor agonists (BIM-28125 and BIM-28131) resulted in increased food intake and an improvement in lean body mass accrual that was related in part to a decrease in muscle protein degradation as assessed by muscle levels of the 14-kDa actin fragment resulting from cleaved actomyosin. Additionally, there was a decrease in circulating inflammatory cytokines in nephrectomized animals treated with ghrelin relative to saline treatment. Ghrelin-treated animals also had a decrease in the expression of IL-1 receptor in the brainstem and a decrease in expression of prohormone convertase-2, an enzyme involved in the processing of proopiomelanocortin to the anorexigenic peptide α-MSH. We conclude that ghrelin treatment in uremia results in improved lean mass accrual in part due to suppressed muscle proteolysis and possibly related to antiinflammatory effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for ghrelin in the central regulation of feeding
Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., & Matsukura, S. (2001) · Nature · doi:10.1038/35051587 · Cited by 3,443
Anatomy and regulation of the central melanocortin system
Cone, R. D. (2005) · Nature Neuroscience · doi:10.1038/nn1455 · Cited by 1,583 · cited 1×
“This system involves two classes of neurons; the first includes anorexigenic neurons that produce POMC, which is cleaved to form -MSH to stimulate melanocortin-4 receptors,producinganorexiaandadecreaseinmusclemass (27, 49 ).”
BackgroundWang, X., Hu, Z., Hu, J., Du, J., & Mitch, W. E. (2006) · Endocrinology · doi:10.1210/en.2006-0251 · Cited by 600
Self-citationNutrition and mortality in hemodialysis
Bergström, J. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v651329 · Cited by 306
Cited by
Wasting in chronic kidney disease
Mak, R. H., Ikizler, A. T., Kovesdy, C. P., Raj, D. S., Stenvinkel, P., & Kalantar-Zadeh, K. (2011) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0019-5 · Cited by 281
The effects of ghrelin on inflammation and the immune system
Baatar, D., Patel, K., & Taub, D. D. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.04.019 · Cited by 257
Dinas, P. C., Markati, A. S., & Carrillo, A. E. (2014) · ISRN Physiology · doi:10.1155/2014/964627 · Cited by 19
Therapeutic potential of ghrelin treatment for unloading-induced muscle atrophy in mice
Koshinaka, K., Toshinai, K., Mohammad, A., Noma, K., Oshikawa, M., Ueno, H., Yamaguchi, H., & Nakazato, M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.086 · Cited by 16
Metadata
- Authors
- DeBoer, M. D., Zhu, X., Levasseur, P. R., Inui, A., Hu, Z., Han, G., Mitch, W. E., Taylor, J. E., Halem, H. A., Dong, J. Z., Datta, R., Culler, M. D., & Marks, D. L.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2007-11-26
- Volume
- 149
- Issue
- 2
- Pages
- 827-835
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2152643580
- Cited by
- 141
- References
- 4
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.